• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ALIOF:US

112.1900 USD 1.5100 1.33%

As of 20:10:01 ET on 11/21/2014.

Snapshot for Actelion Ltd (ALIOF)

Open: 112.9500 Day's Range: 112.1900 - 112.9500 Volume: 861
Previous Close: 113.7000 52wk Range: 75.8038 - 129.2500 1-Yr Rtn: +37.32%

Stock Chart for ALIOF

No chart data available.
  • ALIOF:US 112.3340
  • 1D
  • 1M
  • 1Y
113.7000
Interactive ALIOF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALIOF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 19.0039
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 5.7270
Est. PEG Ratio 1.8504
Market Cap (M USD) 12,804.07
Shares Outstanding (M) 114.13
30 Day Average Volume 516
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.20%
Cash Dividend (CHF) 1.2000
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/16/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALIOF

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for ALIOF

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COOGuy BraunsteinExec VP/Head:Clinical Dev
More Company Profile & Key Executives for ALIOF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil